Performance Analysis Of Neural Network Models For Oxazolines And Oxazoles Derivatives Descriptor Dataset

Neural networks have been used successfully to a broad range of areas such as business, data mining, drug discovery and biology. In medicine, neural networks have been applied widely in medical diagnosis, detection and evaluation of new drugs and treatment cost estimation. In addition, neural networks have begin practice in data mining strategies for the aim of prediction, knowledge discovery. This paper will present the application of neural networks for the prediction and analysis of antitubercular activity of Oxazolines and Oxazoles derivatives. This study presents techniques based on the development of Single hidden layer neural network (SHLFFNN), Gradient Descent Back propagation neural network (GDBPNN), Gradient Descent Back propagation with momentum neural network (GDBPMNN), Back propagation with Weight decay neural network (BPWDNN) and Quantile regression neural network (QRNN) of artificial neural network (ANN) models Here, we comparatively evaluate the performance of five neural network techniques. The evaluation of the efficiency of each model by ways of benchmark experiments is an accepted application. Cross-validation and resampling techniques are commonly used to derive point estimates of the performances which are compared to identify methods with good properties. Predictive accuracy was evaluated using the root mean squared error (RMSE), Coefficient determination(???), mean absolute error(MAE), mean percentage error(MPE) and relative square error(RSE). We found that all five neural network models were able to produce feasible models. QRNN model is outperforms with all statistical tests amongst other four models.

[1]  Kozo Takayama,et al.  Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations , 2004, Pharmaceutical Research.

[2]  M. Z. Rehman,et al.  IMPROVING THE ACCURACY OF GRADIENT DESCENT BACK PROPAGATIONALGORITHM (GDAM) ON CLASSIFICATION PROBLEMS , 2011 .

[3]  H. White Nonparametric Estimation of Conditional Quantiles Using Neural Networks , 1990 .

[4]  Kurt Hornik,et al.  The Design and Analysis of Benchmark Experiments , 2005 .

[5]  C. Zou,et al.  QSAR study of oxazolidinone antibacterial agents using artificial neural networks , 2007 .

[6]  Heekuck Oh,et al.  Neural Networks for Pattern Recognition , 1993, Adv. Comput..

[7]  Heike Trautmann,et al.  Benchmarking evolutionary multiobjective optimization algorithms , 2010, IEEE Congress on Evolutionary Computation.

[8]  Geoffrey E. Hinton,et al.  Learning representations by back-propagating errors , 1986, Nature.

[9]  M C Meyer,et al.  The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[10]  J Bourquin,et al.  Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. , 1997, Pharmaceutical development and technology.

[11]  Geoffrey E. Hinton,et al.  Learning representations by back-propagation errors, nature , 1986 .

[12]  Christopher T. Rhodes,et al.  Artificial Neural Networks: Implications for Pharmaceutical Sciences , 1995 .

[13]  W. Pan,et al.  Formulation Optimization Technique Based on Artificial Neural Network in Salbutamol Sulfate Osmotic Pump Tablets , 2000, Drug development and industrial pharmacy.

[14]  Guang-Bin Huang,et al.  Classification ability of single hidden layer feedforward neural networks , 2000, IEEE Trans. Neural Networks Learn. Syst..

[15]  Bernd Michaelis,et al.  ON THE GRADIENT DESCENT IN BACKPROPAGATION AND ITS SUBSTITUTION BY A GENETIC ALGORITHM , 2000 .

[16]  Gerrit Kateman,et al.  Using artificial neural networks for solving chemical problems Part I. Multi-layer feed-forward networks , 1994 .

[17]  CHUN WEI YAP,et al.  PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..

[18]  Can Çinar,et al.  Artificial neural network based modeling of heated catalytic converter performance , 2005 .

[19]  G E Peck,et al.  Pharmaceutical granulation and tablet formulation using neural networks. , 1996, Pharmaceutical development and technology.

[20]  Amit Gupta,et al.  Weight decay backpropagation for noisy data , 1998, Neural Networks.

[21]  Michael Y. Hu,et al.  Forecasting with artificial neural networks: The state of the art , 1997 .

[22]  Ning Qian,et al.  On the momentum term in gradient descent learning algorithms , 1999, Neural Networks.

[23]  David R. Williams,et al.  Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor. , 2000, Organic letters.

[24]  S. Franzblau,et al.  Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters. , 2010, European journal of medicinal chemistry.

[25]  Torsten Hothorn,et al.  Exploratory and Inferential Analysis of Benchmark Experiments , 2008 .

[26]  Erdogan Köse,et al.  Modelling of colour perception of different age groups using artificial neural networks , 2008, Expert Syst. Appl..

[27]  James W. Taylor A Quantile Regression Neural Network Approach to Estimating the Conditional Density of Multiperiod Returns , 2000 .

[28]  Kozo Takayama,et al.  Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations , 1997 .

[29]  GuanHua Chen,et al.  A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. , 2006, Journal of molecular graphics & modelling.